Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease
The Caerphilly and Speedwell Studies
MRC Epidemiology Unit, Llandough Hospital Penarth, U.K. and Avon Health Authority Bristol, U.K.
Received 1 April 1996; accepted 4 April 1996.
Correspondence: P. M. Sweetnam. MRC Epidemiology Unit. Llandough Hospital. Penarth. South Glamorgan. CF64 2XW.U.K.
Abstract
AIMS: To use the ten year follow-up of the Caerphilly and Speedwell studies to assess the contributions of fibrinogen and viscosity to the prediction of risk of ischaemic heart disease.
METHODS AND RESULTS: Caerphilly and Speedwell are prospective studies based on representative samples of middle-aged males. Ischaemic heart disease morbidity and mortality were defined using hospital notes, repeat electrocardiographs and death certificates. There were 603 incident events among the 4860 men. Age-adjusted relative odds of ischaemic heart disease increased to 3.3 and 3.4 in the 20% of men with the highest levels of fibrinogen and viscosity, respectively. After standardizing for the major cardiovascular risk factors, these relative odds were 2.2 (95% confidence interval 1.6 to 3.1) for fibrinogen and 2.3 (95% confidence interval 1.7 to 3.2) for viscosity. When fibrinogen and viscosity were entered jointly, both remained significant (P<0.0l) predictors. Incidence of ischaemic heart disease increased with increasing fibrinogen at every level of viscosity, and vice versa. Interactions with lipids were also examined. There was no support for the suggestion that risk is independent of cholesterol level when fibrinogen is low.
CONCLUSIONS: Fibrinogen and viscosity are powerful, long term and independent predictors of the risk of ischaemic heart disease.
Key Words: Fibrinogen • viscosity • ischaemic heart disease • prospective study • interactions • cholesterol
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. G.L. de Oliveira, M. T. Murakami, A. C.O. Cintra, J. J. Franco, S. V. Sampaio, and R. K. Arni Functional and structural analysis of two fibrinogen-activating enzymes isolated from the venoms of Crotalus durissus terrificus and Crotalus durissus collilineatus Acta Biochim Biophys Sin, January 1, 2009; 41(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K W Lee, A D Blann, K Jolly, G Y H Lip, and on behalf of the BRUM Investigators Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study Heart, December 1, 2006; 92(12): 1732 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben-Shlomo, and G. Lowe Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study Circulation, November 15, 2005; 112(20): 3080 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woodward, G. D.O. Lowe, D. J. Campbell, S. Colman, A. Rumley, J. Chalmers, B. C. Neal, A. Patel, A. J. Jenkins, B. E. Kemp, et al. Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke Stroke, October 1, 2005; 36(10): 2143 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yarnell, E. McCrum, A. Rumley, C. Patterson, V. Salomaa, G. Lowe, A. Evans, and on behalf of the MONICA Optional Haemostasis Study Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study{dagger} Eur. Heart J., February 2, 2005; 26(4): 332 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.W.G Yarnell, C.C Patterson, P.M Sweetnam, and G.D.O Lowe Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies Eur. Heart J., June 2, 2004; 25(12): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kerlin, B. C. Cooley, B. H. Isermann, I. Hernandez, R. Sood, M. Zogg, S. B. Hendrickson, M. W. Mosesson, S. Lord, and H. Weiler Cause-effect relation between hyperfibrinogenemia and vascular disease Blood, March 1, 2004; 103(5): 1728 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Lee and G. Y. H. Lip Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Babisch, H Ising, and J E J Gallacher Health status as a potential effect modifier of the relation between noise annoyance and incidence of ischaemic heart disease Occup. Environ. Med., October 1, 2003; 60(10): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kamath and G.Y.H. Lip Fibrinogen: biochemistry, epidemiology and determinants QJM, October 1, 2003; 96(10): 711 - 729. [Full Text] [PDF]
|
|
|
|
|
|
F. Kittel, F. Leynen, M. Stam, M. Dramaix, P. de Smet, R. Mak, G. De Backer, and M. Kornitzer Job conditions and fibrinogen in 14226 Belgian workers. The Belstress study Eur. Heart J., December 1, 2002; 23(23): 1841 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G.C. Spencer, D. Gurney, A. D. Blann, D. G. Beevers, and G. Y.H. Lip Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Hypertension, July 1, 2002; 40(1): 61 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sato, M. Nakamura, M. Iida, Y. Naito, A. Kitamura, T. Okamura, Y. Nakagawa, H. Imano, M. Kiyama, H. Iso, et al. Plasma Fibrinogen and Coronary Heart Disease in Urban Japanese Am. J. Epidemiol., September 1, 2000; 152(5): 420 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Gardner, J. R. Lehmann, and D. L. Costa Oil Fly Ash-Induced Elevation of Plasma Fibrinogen Levels in Rats Toxicol. Sci., July 1, 2000; 56(1): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Danesh, R Collins, R Peto, and G.D.O Lowe Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease Eur. Heart J., April 1, 2000; 21(7): 515 - 520. [PDF]
|
|
|
|
|
|
G J Prescott, R J Lee, G R Cohen, R A Elton, A J Lee, F G R Fowkes, and R M Agius Investigation of factors which might indicate susceptibility to particulate air pollution Occup. Environ. Med., January 1, 2000; 57(1): 53 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. G. Yarnell, P. M. Sweetnam, A. Rumley, and G. D. O. Lowe Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease : The Caerphilly Study Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.W. Mulholland, P.C. Elwood, A. Davis, D.I. Thurnham, O. Kennedy, J. Coulter, A. Fehily, and J.J. Strain Antioxidant enzymes, inflammatory indices and lifestyle factors in older men: a cohort analysis QJM, October 1, 1999; 92(10): 579 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1368 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Rosenson, C. C. Tangney, and L. J. Mosca Hormone Replacement Therapy Improves Cardiovascular Risk by Lowering Plasma Viscosity in Postmenopausal Women Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1902 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Rosenson and C. C. Tangney Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction JAMA, May 27, 1998; 279(20): 1643 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Danesh, R. Collins, P. Appleby, and R. Peto Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-analyses of Prospective Studies JAMA, May 13, 1998; 279(18): 1477 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig, M. Sund, B. Filipiak, A. Doring, H. Lowel, and E. Ernst Plasma Viscosity and the Risk of Coronary Heart Disease : Results From the MONICA-Augsburg Cohort Study, 1984 to 1992 Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 768 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Lee, P. I. Mowbray, G. D.O. Lowe, A. Rumley, F. G. R. Fowkes, and P. L. Allan Blood Viscosity and Elevated Carotid Intima-Media Thickness in Men and Women : The Edinburgh Artery Study Circulation, April 21, 1998; 97(15): 1467 - 1473. [Abstract] [Full Text] [PDF]
|
|